Molecular pathology of ALS: what we currently know and what important information is still missing
N Jankovska, R Matej - Diagnostics, 2021 - mdpi.com
Despite an early understanding of amyotrophic lateral sclerosis (ALS) as a disease affecting
the motor system, including motoneurons in the motor cortex, brainstem, and spinal cord …
the motor system, including motoneurons in the motor cortex, brainstem, and spinal cord …
Use of biomarkers in ALS drug development and clinical trials
The past decade has seen a dramatic increase in the discovery of candidate biomarkers for
ALS. These biomarkers typically can either differentiate ALS from control subjects or predict …
ALS. These biomarkers typically can either differentiate ALS from control subjects or predict …
Blood biomarkers in ALS: challenges, applications and novel frontiers
E Sturmey, A Malaspina - Acta Neurologica Scandinavica, 2022 - Wiley Online Library
Amyotrophic lateral sclerosis (ALS) is the most common motor neuron disease among
adults. With diagnosis reached relatively late into the disease process, extensive motor cell …
adults. With diagnosis reached relatively late into the disease process, extensive motor cell …
Unsupervised machine learning identifies distinct ALS molecular subtypes in post-mortem motor cortex and blood expression data
H Marriott, R Kabiljo, GP Hunt, AA Khleifat… - Acta neuropathologica …, 2023 - Springer
Amyotrophic lateral sclerosis (ALS) displays considerable clinical and genetic
heterogeneity. Machine learning approaches have previously been utilised for patient …
heterogeneity. Machine learning approaches have previously been utilised for patient …
[HTML][HTML] State of the art and the dark side of amyotrophic lateral sclerosis
A Musarò - World journal of biological chemistry, 2010 - ncbi.nlm.nih.gov
Amyotrophic lateral sclerosis (ALS) is a disorder that involves the degeneration of motor
neurons, muscle atrophy, and paralysis. In a few familiar forms of ALS, mutations in the …
neurons, muscle atrophy, and paralysis. In a few familiar forms of ALS, mutations in the …
Biochemical markers in CSF of ALS patients
SD Sussmuth, J Brettschneider… - Current medicinal …, 2008 - ingentaconnect.com
Amyotrophic lateral sclerosis (ALS) is the most common form of motor neuron diseases
(MND) characterized by progressive selective degeneration of motor neurons. Although …
(MND) characterized by progressive selective degeneration of motor neurons. Although …
Destination amyotrophic lateral sclerosis
Amyotrophic Lateral Sclerosis (ALS) is a prototypical neurodegenerative disease
characterized by progressive degeneration of motor neurons both in the brain and spinal …
characterized by progressive degeneration of motor neurons both in the brain and spinal …
[HTML][HTML] Lessons of ALS imaging: pitfalls and future directions—a critical review
P Bede, O Hardiman - NeuroImage: Clinical, 2014 - Elsevier
Background While neuroimaging in ALS has gained unprecedented momentum in recent
years, little progress has been made in the development of viable diagnostic, prognostic and …
years, little progress has been made in the development of viable diagnostic, prognostic and …
Targeted sequencing panels in Italian ALS patients support different etiologies in the ALS/FTD continuum
A Bartoletti-Stella, V Vacchiano, S De Pasqua… - Journal of …, 2021 - Springer
Abstract Background 5–10% of amyotrophic lateral sclerosis (ALS) patients presented a
positive family history (fALS). More than 30 genes have been identified in association with …
positive family history (fALS). More than 30 genes have been identified in association with …
Pathophysiological and diagnostic implications of cortical dysfunction in ALS
N Geevasinga, P Menon, PH Özdinler… - Nature Reviews …, 2016 - nature.com
Cortical dysfunction—specifically, the development of hyperexcitability—seems to be an
early and intrinsic feature of sporadic and familial amyotrophic lateral sclerosis (ALS) …
early and intrinsic feature of sporadic and familial amyotrophic lateral sclerosis (ALS) …